Intravacc has announced the signing of a strategic partnership agreement with Dutch-based CimCure for in-licensing CimCure’s iBoost technology.

Softbox has announced the launch of Tempcell™ ECO, a new curbside-recyclable temperature control parcel shipper.

In a strategic new alignment, Van Heron Labs and Foresight Biosciences will take aim at surpassing the boundaries in a burgeoning field: biotechnology.

Codexis, Inc., a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce a partnership to engineer enzymes to deliver differentiated and cost-effective solutions for the enzymatic synthesis of DNA.

Kerafast Inc. has announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications, enabling studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 containment.

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.

GSK’s scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered into human clinical trials.

Waters Corporation has announced a new fragmentation technique and an imaging option for its high-resolution mass spectrometers.

Lonza has expanded its cell culture media portfolio with the addition of the GSv9™ Media and Feeds, providing a fully integrated solution specifically designed to optimize recombinant protein production using Lonza’s GS Gene Expression System®.

Infectivity assays have shown that Affimer reagents can prevent infection of human cells by a SARS-CoV-2 model virus.